Solana Company (HSDT) is a Medical - Devices company in the Healthcare sector, currently trading at $1.98. It has a SharesGrow Score of 36/100, indicating a weak investment profile with 0 out of 7 criteria passed.
Valuation: HSDT trades at a trailing Price-to-Earnings (P/E) of -1 (S&P 500 average ~25).
Financials: revenue is $6M, +339.9%/yr average growth. Net income is $41M (loss), growing at -81.3%/yr. Net profit margin is -679.6% (negative). Gross margin is 91.7% (+50.5 pp trend).
Balance sheet: total debt is $0 against $301M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 10.33 (strong liquidity). Debt-to-assets is 0%. Total assets: $304M.
Analyst outlook: 2 / 4 analysts rate HSDT as buy (50%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future 40/100 (Partial), Income 10/100 (Fail).
